Question · asked by 1 review
Intratympanic corticosteroids vs no treatment or versus placebo: Ear pain: at the time of injection
- Population
- sudden sensorineural hearing loss
- Intervention
- Intratympanic corticosteroids
- Comparison
- no treatment or versus placebo
- Outcome
- Ear pain: at the time of injection
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intratympanic corticosteroids vs no treatment or versus placebo Ear pain at the time of intratympanic injection · sudden sensorineural hearing loss Intratympanic corticosteroids for sudden sensorineural hearing loss (2022) · Cochrane Headline outcomes only | no estimate extracted | 44 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intratympanic corticosteroids for sudden sensorineural hearing loss 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Intratympanic corticosteroids vs systemic corticosteroids · sudden sensorineural hearing loss · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.